WYMM Tour: Birmingham
Thursday 3rd October 2024, 10:00 - 17:00 GMT - Birmingham, United Kingdom (timings subject to change)
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Thursday 3rd October 2024 to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Full agenda and venue details coming soon.
Agenda
10:00 — 17:00 GMT | Agenda (subject to change) | Speaker |
|---|---|---|
10:00 — 10:30 | Registration and breakfast | |
10:30 — 11:00 | Welcome | Rich Compton, Oxford Nanopore Technologies |
11:00 — 11:35 | The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study | Hannah Titheradge, Clinical Genetics at Birmingham Women's and Children's NHS Foundation Trust, United Kingdom Lorraine Hartles-Spencer, West Midlands Regional Genetics Lab, United Kingdom |
11:35 — 12:00 | Towards multi-modal liquid biopsy assays | Florent Mouliere, CRUK National Biomarker Centre, University of Manchester |
12:00 — 13:30 | Lunch | |
13:30 — 13:55 | Oxford Nanopore Technologies Bioinformatics update | Dan Fordham, Oxford Nanopore Technologies |
13:55 — 14:20 | Differential isoform regulation in the human brain across regions, development, and between neuropsychiatric disorder cases and controls | Sofia Kudasheva, Earlham Institute |
14:20 — 14:45 | The era of complete human genomes | Cora Vacher, Oxford Nanopore Technologies |
14:45 — 15:45 | Networking session | |
15:45 — 16:15 | Panel Q&A session | Moderated by Nirmala Santiapillai, Oxford Nanopore Technologies |
16:15 — 16:50 | Brain tumour classification using nanopore sequencing | Simon Deacon, University of Nottingham |
16:50 — 17:00 | Closing remarks | Oxford Nanopore Technologies |
17:00 — 20:00 | Drinks reception and networking |
Speakers
)
Welcome
Rich Compton, SVP, Sales & Commercial Operations, Oxford Nanopore Technologies
Richard joined Oxford Nanopore in 2016 to help build our commercial team from scratch. He is now res...
)
The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study
Hannah Titheradge, Consultant, Clinical Genetics at Birmingham Women's and Children's NHS Foundation Trust, United Kingdom
Dr. Hannah Titheradge is a Consultant in Clinical Genetics at the Birmingham Women’s and Children’s ...
)
The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study
Lorraine Hartles-Spencer, Principal Clinical Scientist, West Midlands Regional Genetics Lab, United Kingdom
Lorraine Hartles-Spencer is currently a Principal Clinical Scientist working within the Birmingham W...
)
Towards multi-modal liquid biopsy assays
Florent Mouliere, CRUK National Biomarker Centre, University of Manchester
Florent Mouliere leads the Nucleic Acids Biomarker team at the Cancer Research UK National Biomarker...
)
Bioinformatics update
Dan Fordham, Director, Strategic Product Management, EMEA, Oxford Nanopore Technologies
Dr. Dan Fordham is Director, Strategic Product Management EMEA at Oxford Nanopore Technologies focus...
)
The era of complete human genomes
Cora Vacher, Associate Director, Segment Marketing, Oxford Nanopore Technologies
Cora Vacher is the Associate Director of Segment Marketing at Oxford Nanopore Technologies. Cora is ...
)
Differential isoform regulation in the human brain across regions, development, and between neuropsychiatric disorder cases and controls
Sofia Kudasheva, PhD Student, Earlham Institute
Sofia is a fourth year PhD student working in the Haerty lab at the Earlham Institute, UK. Her resea...
)
Panel Moderator
Nirmala Santiapillai, Oxford Nanopore Technologies
...
)
Carolyn Tregidgo, VP Applied Development , Oxford Nanopore Technologies
Carolyn Tregidgo is a technical leader with significant experience in DNA sequencing of rare disease...
)
Brain tumour classification using nanopore sequencing
Simon Deacon, University of Nottingham
I am a trainee neuropathologist at Nottingham University Hospitals NHS Trust. I am currently underta...
Resources
Product brochures
'%20transform='translate(-1229%20-954)'%3e%3cg%20clip-path='url(%23kg9jt4e4eb)'%20transform='translate(1229%20954)'%3e%3cpath%20fill='%23455556'%20d='M0%200h28.313v58.624H0V0z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
'%20transform='translate(-130%20-954)'%3e%3cg%20clip-path='url(%23vjs606norb)'%20transform='rotate(-180%2079.5%20506.5)'%3e%3cpath%20fill='%23455556'%20d='M0%200h28.313v58.624H0V0z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
)
)
)
White papers
)
)
)
Case Studies
)
)